2025-09-23 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive Co. (CL) based on the data you provided, presented in an English report format with numerical summaries and analysis.

## Colgate-Palmolive Co. (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive is a global consumer products company focused on the production, distribution and provision of household, health care, personal care and pet nutrition products.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (CL):** 7.67%
*   **Cumulative Return (VOO):** 106.97%
*   **Absolute Divergence:** -97.9%
*   **Relative Divergence:** 0.0 (This indicates CL is at the very low end of its historical relative performance range compared to VOO).

**Analysis:** CL has significantly underperformed the S&P 500 (VOO) over the period examined. The relative divergence suggests this underperformance is near the worst it has been historically.

**Alpha and Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta  | Cap(B) |
|------------|---------|---------|----------|-------|--------|
| 2015-2017  | 13.0%   | 4.5%    | -16.0%   | 0.0   | 61.0   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%   | 0.1   | 48.1   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%   | 0.1   | 55.6   |
| 2018-2020  | 18.0%   | 65.2%   | -2.0%    | 0.6   | 69.1   |
| 2019-2021  | 30.0%   | 58.6%   | -19.0%   | 0.7   | 69.0   |
| 2020-2022  | 7.0%    | 69.0%   | 5.0%     | 0.7   | 63.7   |
| 2021-2023  | 6.0%    | 69.0%   | -12.0%   | 0.8   | 64.4   |
| 2022-2024  | 13.0%   | 69.0%   | -12.0%   | 0.8   | 73.5   |
| 2023-2025  | -6.0%   | 70.6%   | -64.0%   | 0.3   | 65.6   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows fluctuating performance over the different time periods.
*   **MDD:** The Maximum Drawdown indicates significant potential losses, especially in recent periods.
*   **Alpha:**  Alpha is mostly negative, suggesting CL has underperformed its benchmark on a risk-adjusted basis.  The recent period (2023-2025) shows a particularly large negative alpha.
*   **Beta:**  Beta values are relatively low (mostly below 1), indicating lower volatility compared to the market (S&P 500).

### 2. Recent Price Action

*   **Current Price:** 81.17
*   **Last Market Data:** Price: 79.36, Previous Close: 81.17, Change: -2.23
*   **5-Day Moving Average:** 81.71
*   **20-Day Moving Average:** 83.48
*   **60-Day Moving Average:** 86.09

**Analysis:** The stock price is currently below all three moving averages, indicating a short-term downward trend. The recent price drop (change of -2.23) suggests some negative momentum. The Last Market Data show the stock price is still decreasing.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3367 (Low Risk)
*   **RSI:** 35.47 (Approaching oversold territory)
*   **PPO:** -0.23
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (3 shares - Safe - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Short-term decrease)
*   **Expected Return (%):** -3706.8 (Significant underperformance vs. S&P 500 expected over a long-term investment horizon)

**Analysis:**

*   The MRI suggests a low-risk environment, but the low RSI value indicates the stock might be oversold and could potentially rebound.
*   The negative PPO confirms the downward trend.
*   The Hybrid Signal suggest to "Buy 90% of cash (3 shares - Safe)", so it's good to buy some stocks now
*   The 20-day relative divergence change also indicates recent short-term underperformance.
*   The extremely negative expected return suggests analysts anticipate significant underperformance compared to the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **[2025-09-22] RBC Trims Price Target:** RBC Capital lowered its price target to $96, maintaining a Sector Perform rating.
*   **[2025-09-19] Zacks Article:**  Zacks highlights Colgate-Palmolive as a strong growth stock.
*   **[2025-09-17] Packaging Modification:** Colgate agreed to modify toothpaste packaging after scrutiny.
*   **[2025-09-17 & 2025-09-16] Oil Prices:** News related to oil prices is less directly relevant, but could impact input costs.
*   **[2025-09-16] Sustainable Packaging:** Colgate-Palmolive partnered with Erthos for sustainable biopolymer packaging.

**Analysis:** The news is mixed. A price target reduction is negative, but the Zacks article presents a positive outlook. The packaging modification is likely a minor event. The focus on sustainable packaging is a positive long-term trend.

### 4-2) Analyst Opinions

*   **Mean Analyst Rating:**  (Neutral - Data Missing)
*   **Number of Opinions:** 18
*   **Target Price (avg/high/low):** 95.22 / 106.00 / 83.00

**Analysis:** The average analyst target price ($95.22) is significantly higher than the current price ($79.36), suggesting potential upside.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-08-01 | 0.92 | 5.11 B$   |
| 2025-04-25 | 0.85 | 4.91 B$   |
| 2024-10-25 | 0.9  | 5.03 B$   |
| 2024-07-26 | 0.89 | 5.06 B$   |
| 2025-08-01 | 0.89 | 5.06 B$   |

**Analysis:**  Earnings per share (EPS) and revenue figures show consistent performance over the last few quarters, with a slight uptick in the most recent quarter (2025-08-01).

### 6. Financial Information: Revenue and Profitability

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $5.11B  | 60.06%        |
| 2025-03-31   | $4.91B  | 60.82%        |
| 2024-12-31   | $4.95B  | 60.30%        |
| 2024-09-30   | $5.03B  | 61.08%        |
| 2024-06-30   | $5.06B  | 60.62%        |

**Analysis:** Revenue has been relatively stable around $5 billion per quarter. The profit margin is consistently high, indicating strong profitability.

### 6. Financial Information: Capital and Profitability

| Quarter      | Equity  | ROE       |
|--------------|---------|-----------|
| 2025-06-30   | $0.70B  | 105.84%   |
| 2025-03-31   | $0.36B  | 190.08%   |
| 2024-12-31   | $0.21B  | 348.58%   |
| 2024-09-30   | $0.43B  | 169.43%   |
| 2024-06-30   | $0.12B  | 594.31%   |

**Analysis:** Equity fluctuates, but the Return on Equity (ROE) is exceptionally high, suggesting efficient use of shareholder equity to generate profits. However, very high ROE values can sometimes be a red flag if equity is unusually low.

### 7. Overall Summary and Analysis

Colgate-Palmolive (CL) is currently showing mixed signals.  While the company demonstrates stable revenue and very high profit margins and ROE, its stock has significantly underperformed the S&P 500. Recent price action is negative, and technical indicators suggest a potential oversold condition, but the overall trend appears to be downward. Analyst opinions are generally positive, with a target price suggesting upside potential. The recent news is a mixed bag, with some positive developments (sustainable packaging) offset by a price target reduction. The biggest concern is the company's underperformance relative to the market and the negative expected return. Investors should carefully consider these factors before making investment decisions. It's crucial to investigate *why* the expected return is so negative despite the seemingly solid fundamentals. Are there specific challenges or risks that are not immediately apparent from this data? A deeper dive into the company's strategic outlook and competitive landscape is warranted.
